Resona Asset Management Co. Ltd. Invests $695,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Resona Asset Management Co. Ltd. purchased a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 8,902 shares of the company’s stock, valued at approximately $695,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Kestra Investment Management LLC bought a new position in shares of Prestige Consumer Healthcare in the fourth quarter worth $27,000. CIBC Private Wealth Group LLC raised its stake in shares of Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock valued at $34,000 after purchasing an additional 152 shares during the period. Headlands Technologies LLC purchased a new stake in Prestige Consumer Healthcare during the 4th quarter worth about $40,000. GAMMA Investing LLC lifted its holdings in Prestige Consumer Healthcare by 18.9% during the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after purchasing an additional 220 shares in the last quarter. Finally, Huntington National Bank grew its holdings in Prestige Consumer Healthcare by 133.2% during the 4th quarter. Huntington National Bank now owns 1,481 shares of the company’s stock valued at $116,000 after buying an additional 846 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Stock Performance

NYSE PBH opened at $80.66 on Friday. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $90.04. The company has a fifty day moving average of $84.43 and a 200-day moving average of $79.75. The company has a market capitalization of $4.00 billion, a P/E ratio of 18.89, a P/E/G ratio of 2.69 and a beta of 0.47. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PBH. StockNews.com downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday. Oppenheimer raised their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Royal Bank of Canada upped their price target on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a report on Friday, March 21st. Finally, DA Davidson boosted their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.